Cargando…

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction

BACKGROUND: This study evaluated whether pathogen reduction technology (PRT) in plasma and platelets using amotosalen/ultraviolet A light (A/UVA) or in red blood cells using amustaline/glutathione (S‐303/GSH) may be used as the sole mitigation strategy preventing transfusion‐transmitted West Nile (W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stramer, Susan L., Lanteri, Marion C., Brodsky, Jaye P., Foster, Gregory A., Krysztof, David E., Groves, Jamel A., Townsend, Rebecca L., Notari, Edward, Bakkour, Sonia, Stone, Mars, Simmons, Graham, Spencer, Bryan, Tonnetti, Laura, Busch, Michael P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Blood Donors and Blood Collection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541364/ https://www.ncbi.nlm.nih.gov/pubmed/35726756 http://dx.doi.org/10.1111/trf.16950

Ejemplares similares

Failure of self-disclosure of deferrable risk behaviors associated with transfusion-transmissible infections in blood donors
por: Wong, Horas Tze Hoo, et al.
Publicado: (2015)

Determinants of blood donation willingness in the European Union: a cross‐country perspective on perceived transfusion safety, concerns, and incentives
por: Huis in ‘t Veld, Elisabeth M.J., et al.
Publicado: (2019)

Estimation of the number of blood donors during the COVID‐19 incubation period across China and analysis of prevention and control measures for blood transfusion transmission
por: Yuan, Zhaohu, et al.
Publicado: (2020)

Performance characteristics of a novel blood bag in-line closure device and subsequent product quality assessment
por: Serrano, Katherine, et al.
Publicado: (2010)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018)

Ensuring HLA‐matched platelet support requires an ethnic diverse donor population
por: Kreuger, Aukje L., et al.
Publicado: (2020)

First results of a ferritin‐based blood donor deferral policy in the Netherlands
por: Vinkenoog, Marieke, et al.
Publicado: (2020)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019)

Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Barriers to blood donation on social media: An analysis of Facebook and Twitter posts
por: Ramondt, Steven, et al.
Publicado: (2020)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men
por: Castillo, Gisell, et al.
Publicado: (2022)

How to increase first‐time donors' returns? The postdonation letter's content can make a difference
por: Moussaoui, Lisa S., et al.
Publicado: (2022)

Sexual risk behavior questions: Understanding and mitigating donor discomfort
por: Haw, Jennie, et al.
Publicado: (2021)

Plasmavigilance—Adverse events among US Source plasma donors
por: Schreiber, George B., et al.
Publicado: (2021)

A robust autonomous method for blood demand forecasting
por: Turkulainen, Esa V., et al.
Publicado: (2022)

What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation
por: France, Christopher R., et al.
Publicado: (2022)

Predicting vasovagal reactions to a virtual blood donation using facial image analysis
por: Rudokaite, Judita, et al.
Publicado: (2022)

‘Stay at home and limit contact’: The impact of stay‐at‐home advice on the behavior of Australian donors aged 70 and over in the first year of the pandemic
por: Naing, Sanda, et al.
Publicado: (2022)

Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences
por: France, Christopher R., et al.
Publicado: (2022)

The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022)

Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022)

HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada
por: Lambert, Gilles, et al.
Publicado: (2022)

Communicating the move to individualized donor selection policy: Framing messages focused on recipients and safety
por: Ferguson, Eamonn, et al.
Publicado: (2022)

Perspectives on the impact of storage duration on blood quality and transfusion outcomes
por: Roback, J. D.
Publicado: (2016)

Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19
por: Berzuini, Alessandra, et al.
Publicado: (2020)

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
por: Nickel, Robert Sheppard, et al.
Publicado: (2020)

Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system
por: de Bruin, Sanne, et al.
Publicado: (2019)

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
por: Zeidan, Amer M., et al.
Publicado: (2022)

Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology
por: Girard, Yvette A., et al.
Publicado: (2020)

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
por: Xia, Xinyi, et al.
Publicado: (2020)

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
por: Cappy, Pierre, et al.
Publicado: (2020)

Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology
por: Sow, Cissé, et al.
Publicado: (2020)

COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
por: Gerber, Gloria F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3k47imci5e02k504jq2q61ap4q